Challenges in circulating tumour cell research.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

During the past ten years, circulating tumour cells (CTCs) have received enormous attention as new biomarkers and the subject of basic research. Although CTCs are already used in numerous clinical trials, their clinical utility is still under investigation. Many issues regarding the detection and characterization of CTCs remain unknown. In this Opinion article, we propose a conceptual framework of CTC assays and point out current challenges of CTC research, which might structure this dynamic field of translational cancer research.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Nat Rev Cancer

Title: Nature reviews. Cancer

Publisher: Springer Science and Business Media LLC

ISSN (Electronic): 1474-1768

ISSN (Print): 1474-175X

Publication date (Electronic): September 2014

Volume: 14

Issue: 9

Affiliations

[1 ] 1] University Medical Centre, Saint-Eloi Hospital, Institute of Medicine Regenerative &Biotherapy, Department of Cellular and Tissular Biopathology of Tumors, Laboratory of Rare Human Circulating Cells, 80 Avenue Augustin Fliche 34295 Montpellier Cedex 5, Montpellier, France. [2] University Institute of Clinical Research UM1 - EA2415 - Epidemiology, Biostatistics &Public Health, 641, Avenue du Doyen Gaston GIRAUD 34093 Montpellier Cedex 5, Montpellier, France.

[2 ] Department of Tumor Biology, University Medical Center, Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany.

Article

Publisher Item ID: nrc3820

DOI: 10.1038/nrc3820

PubMed ID: 25154812

SO-VID: 8d4c387f-968a-4e8b-8d8e-734780528a53

History

Data availability:

Comments

Comment on this article

scite_

Cited by 511

See all cited by

- Version 1